About Fiagon
Fiagon is a company based in Hennigsdorf (Germany) founded in 2007 by Dirk Mucha was acquired by Hemostasis in May 2022. Fiagon has raised $8.5 million across 3 funding rounds from investors including Intersect ENT, German Startups Group and longone.com. Fiagon offers products and services including VirtuEye, Navigation System, and Navigation Instruments. Fiagon operates in a competitive market with competitors including Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
- Headquarter Hennigsdorf, Germany
- Founders Dirk Mucha
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fiagon Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.5 M (USD)
in 3 rounds
-
Latest Funding Round
$8.5 M (USD), Series D
Mar 17, 2016
-
Investors
Intersect ENT
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fiagon
Fiagon offers a comprehensive portfolio of products and services, including VirtuEye, Navigation System, and Navigation Instruments.
Contactless tool for fast patient registration in surgical settings.
Electromagnetic system for precise ENT and CMF surgery operations.
Flexible instruments with additional functions like suction for accurate navigation.
Funding Insights of Fiagon
Fiagon has successfully raised a total of $8.5M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $8.5 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fiagon
Fiagon has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Intersect ENT, German Startups Group and longone.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in early & growth stage tech companies in Europe
|
Locked | Locked | Locked | |
|
Early-stage investments are provided by Cascara Ventures in life sciences.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Fiagon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fiagon
Investment portfolio details for Fiagon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fiagon
Detailed financials for Fiagon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fiagon Comparisons
Peer comparison for Fiagon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fiagon
Fiagon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
MRI-guided minimally invasive procedures for brain and heart are developed.
|
|
| Locked | Locked | Locked |
Developer of a device for tumor localization
|
|
| Locked | Locked | Locked |
Developer of surgical navigation and image guidance system for endovascular procedures
|
Detailed competitors of Fiagon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fiagon
Complete news archive for Fiagon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fiagon
Fiagon was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Fiagon is headquartered in Hennigsdorf, Germany. It is registered at Hennigsdorf, Brandenburg, Germany.
Fiagon is a funded company, having raised a total of $8.5M across 3 funding rounds to date.
Fiagon was founded in 2007 in Hennigsdorf, Germany, within the medical devices sector. Clinical navigation systems are provided to healthcare providers for surgical applications, including ENT, oral and maxillofacial surgery, and neurosurgery. Electromagnetic tracking matrix algorithms and pointer technology are employed to maintain precision with flexible instruments. The CUBE virtual guidance platform is offered for ENT and skull base procedures, while proprietary FlexSensor technology supports specialized navigation solutions.
Fiagon's top competitors include Augmedics, Proprio and ClearPoint Neuro.
Fiagon offers VirtuEye, Navigation System, and Navigation Instruments.
Fiagon has 5 investors. Key investors include Intersect ENT, German Startups Group, longone.com, Cascara Ventures, and Hemostasis.